Webinar replay

Biopharma Dealmaking in 2021: Trends and Transformation

After a turbulent year of remote dealmaking under COVID-19 restrictions, the biopharma sector has kicked off 2021 with renewed vigor. Billion dollar deals abound, merger and acquisition activities are accelerating, and deals are being made earlier and faster than ever.
In this exclusive webinar, Chris Dokomajilar, founder and CEO of DealForma, and Gilles Toulemonde, CEO of Inova, will present the trends they are tracking and speak to the ongoing digital transformation of biopharma dealmaking. They'll discuss what deals have been done so far in 2021, identify some of the difficulties that pharma companies are experiencing in attracting biotechs, and explain what to watch in deal making and partnering best practices for the second half of 2021.
Watch this replay to get expert insights from our panelists:
Chris Dokomajilar
Chris Dokomajilar
Founder & CEO
Gilles Toulemonde

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 150 life science companies, including 50% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.